T0	Participants 90 178	patients with lower urinary tract symptoms associated with benign prostatic hyperplasia.
T1	Participants 180 295	Patient preference for benign prostatic hyperplasia (BPH) treatment with the Î±(1)-blockers, tamsulosin or silodosin
T2	Participants 341 342	.
T3	Participants 343 414	Japanese patients with lower urinary tract symptoms associated with BPH
T4	Participants 824 918	102 patients (mean age 70.3 years) were enrolled and 84 (n = 42 per group) completed the study
T5	Participants 1398 1411	that patients